With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

Looking ahead to 2030, our model projects AMD could trade at an average price of $723.49, with a potential range between $542.62 and $904.37. This represents a potential 39.7% return from today's ...

SpaceX grew its U.S. market share 4x in 17 years, conducting 82% of U.S. space launches in 2025. SpaceX targets a $75B IPO — nearly 3x the all-time record. See the 10 biggest IPOs ever and how they ...